Strong presales and Cannes buzz for Na Hong-jin’s sci-fi thriller have built interest, yet trader consensus centers on a modest domestic opening because of the 156-minute runtime, midweek September 9 launch, and roughly 1,500-theater rollout—the widest for a Korean-language film since Parasite. South Korea’s robust $11.3 million debut and 1.5 million admissions confirm core-audience draw, while 77% Rotten Tomatoes and mixed Metacritic scores signal limited mainstream crossover potential. Comparable imports and fall scheduling further cap upside, leaving the sub-$6 million bracket as the clearest favorite amid uncertain word-of-mouth and competition from other September releases.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว"Hope" Opening Weekend Box Office
<6m 44%
9-10m 29%
6-7m 27%
7-8m 23%
<6m
44%
6-7m
27%
7-8m
23%
8-9m
21%
9-10m
29%
10m+
19%
<6m 44%
9-10m 29%
6-7m 27%
7-8m 23%
<6m
44%
6-7m
27%
7-8m
23%
8-9m
21%
9-10m
29%
10m+
19%
If the reported value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Please note, this market will resolve according to the The Numbers figures provided under Weekend Box Office Performance for the 3-day weekend (which typically includes Thursday's previews), regardless of whether domestic refers to only the USA, or to USA and Canada, etc.
If there is ambiguity as to whether the resolution source's figures are final, this market will remain open until both https://www.boxofficemojo.com/ and https://www.the-numbers.com/ have confirmed their finalized figures.
If there is no final data available by September 18, 2026, 11:59 PM ET, another credible resolution source will be chosen.
ตลาดเปิดเมื่อ: Sep 9, 2026, 10:30 AM ET
ผู้ตัดสินผล
0x69c47De9D...If the reported value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Please note, this market will resolve according to the The Numbers figures provided under Weekend Box Office Performance for the 3-day weekend (which typically includes Thursday's previews), regardless of whether domestic refers to only the USA, or to USA and Canada, etc.
If there is ambiguity as to whether the resolution source's figures are final, this market will remain open until both https://www.boxofficemojo.com/ and https://www.the-numbers.com/ have confirmed their finalized figures.
If there is no final data available by September 18, 2026, 11:59 PM ET, another credible resolution source will be chosen.
ผู้ตัดสินผล
0x69c47De9D...Strong presales and Cannes buzz for Na Hong-jin’s sci-fi thriller have built interest, yet trader consensus centers on a modest domestic opening because of the 156-minute runtime, midweek September 9 launch, and roughly 1,500-theater rollout—the widest for a Korean-language film since Parasite. South Korea’s robust $11.3 million debut and 1.5 million admissions confirm core-audience draw, while 77% Rotten Tomatoes and mixed Metacritic scores signal limited mainstream crossover potential. Comparable imports and fall scheduling further cap upside, leaving the sub-$6 million bracket as the clearest favorite amid uncertain word-of-mouth and competition from other September releases.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว



ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย